Literature DB >> 33373375

Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.

Faris Durmo1, Anna Rydhög2, Frederik Testud3, Jimmy Lätt2, Benjamin Schmitt4, Anna Rydelius5, Elisabet Englund6, Johan Bengzon7, Peter van Zijl8,9, Linda Knutsson8,10, Pia C Sundgren1,2,11.   

Abstract

PURPOSE: Radiological assessment of primary brain neoplasms, both high (HGG) and low grade tumors (LGG), based on contrast-enhancement alone can be inaccurate. We evaluated the radiological value of amide proton transfer weighted (APTw) MRI as an imaging complement for pre-surgical radiological diagnosis of brain tumors.
METHODS: Twenty-six patients were evaluated prospectively; (22 males, 4 females, mean age 55 years, range 26-76 years) underwent MRI at 3T using T1-MPRAGE pre- and post-contrast administration, conventional T2w, FLAIR, and APTw imaging pre-surgically for suspected primary/secondary brain tumor. Assessment of the additional value of APTw imaging compared to conventional MRI for correct pre-surgical brain tumor diagnosis. The initial radiological pre-operative diagnosis was based on the conventional contrast-enhanced MR images. The range, minimum, maximum, and mean APTw signals were evaluated. Conventional normality testing was performed; with boxplots/outliers/skewness/kurtosis and a Shapiro-Wilk's test. Mann-Whitney U for analysis of significance for mean/max/min and range APTw signal. A logistic regression model was constructed for mean, max, range and Receiver Operating Characteristic (ROC) curves calculated for individual and combined APTw signals.
RESULTS: Conventional radiological diagnosis prior to surgery/biopsy was HGG (8 patients), LGG (12 patients), and metastasis (6 patients). Using the mean and maximum: APTw signal would have changed the pre-operative evaluation the diagnosis in 8 of 22 patients (two LGGs excluded, two METs excluded). Using a cut off value of >2.0% for mean APTw signal integral, 4 of the 12 radiologically suspected LGG would have been diagnosed as high grade glioma, which was confirmed by histopathological diagnosis. APTw mean of >2.0% and max >2.48% outperformed four separate clinical radiological assessments of tumor type, P-values = .004 and = .002, respectively.
CONCLUSIONS: Using APTw-images as part of the daily clinical pre-operative radiological evaluation may improve diagnostic precision in differentiating LGGs from HGGs, with potential improvement of patient management and treatment.

Entities:  

Mesh:

Year:  2020        PMID: 33373375      PMCID: PMC7771875          DOI: 10.1371/journal.pone.0244003

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  47 in total

Review 1.  Glioblastoma survival: has it improved? Evidence from population-based studies.

Authors:  Adelheid Woehrer; Luc Bauchet; Jill S Barnholtz-Sloan
Journal:  Curr Opin Neurol       Date:  2014-12       Impact factor: 5.710

2.  3D Slicer as an image computing platform for the Quantitative Imaging Network.

Authors:  Andriy Fedorov; Reinhard Beichel; Jayashree Kalpathy-Cramer; Julien Finet; Jean-Christophe Fillion-Robin; Sonia Pujol; Christian Bauer; Dominique Jennings; Fiona Fennessy; Milan Sonka; John Buatti; Stephen Aylward; James V Miller; Steve Pieper; Ron Kikinis
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

Review 3.  Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review.

Authors:  Ron Batash; Noam Asna; Pamela Schaffer; Nicole Francis; Moshe Schaffer
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

4.  The pH sensitivity of APT-CEST using phosphorus spectroscopy as a reference method.

Authors:  Jan-Rüdiger Schüre; Manoj Shrestha; Stella Breuer; Ralf Deichmann; Elke Hattingen; Marlies Wagner; Ulrich Pilatus
Journal:  NMR Biomed       Date:  2019-07-19       Impact factor: 4.044

5.  Amide proton transfer imaging for differentiation of benign and atypical meningiomas.

Authors:  Bio Joo; Kyunghwa Han; Yoon Seong Choi; Seung-Koo Lee; Sung Soo Ahn; Jong Hee Chang; Seok-Gu Kang; Se Hoon Kim; Jinyuan Zhou
Journal:  Eur Radiol       Date:  2017-07-07       Impact factor: 5.315

6.  Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules.

Authors:  Michael P Fay; Michael A Proschan
Journal:  Stat Surv       Date:  2010

7.  Diagnostic accuracy and interobserver variability of pulsed arterial spin labeling for glioma grading.

Authors:  M J Kim; H S Kim; J-H Kim; K-G Cho; S Y Kim
Journal:  Acta Radiol       Date:  2008-05       Impact factor: 1.990

Review 8.  Temozolomide-associated hypermutation in gliomas.

Authors:  Serah Choi; Yao Yu; Matthew R Grimmer; Michael Wahl; Susan M Chang; Joseph F Costello
Journal:  Neuro Oncol       Date:  2018-09-03       Impact factor: 12.300

9.  Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy.

Authors:  Shanshan Jiang; Charles G Eberhart; Michael Lim; Hye-Young Heo; Yi Zhang; Lindsay Blair; Zhibo Wen; Matthias Holdhoff; Doris Lin; Peng Huang; Huamin Qin; Alfredo Quinones-Hinojosa; Jon D Weingart; Peter B Barker; Martin G Pomper; John Laterra; Peter C M van Zijl; Jaishri O Blakeley; Jinyuan Zhou
Journal:  Clin Cancer Res       Date:  2018-10-26       Impact factor: 12.531

10.  Normality tests for statistical analysis: a guide for non-statisticians.

Authors:  Asghar Ghasemi; Saleh Zahediasl
Journal:  Int J Endocrinol Metab       Date:  2012-04-20
View more
  4 in total

1.  3D Amide Proton Transfer-Weighted Imaging for Grading Glioma and Correlating IDH Mutation Status: Added Value to 3D Pseudocontinuous Arterial Spin Labelling Perfusion.

Authors:  Huimin Hou; Weibo Chen; Yanzhao Diao; Yuhan Wang; Li Zhang; Liming Wang; Min Xu; Jinchao Yu; Tao Song; Yu Liu; Zhenguo Yuan
Journal:  Mol Imaging Biol       Date:  2022-08-12       Impact factor: 3.484

Review 2.  Molecular Imaging of Brain Tumors and Drug Delivery Using CEST MRI: Promises and Challenges.

Authors:  Jianpan Huang; Zilin Chen; Se-Weon Park; Joseph H C Lai; Kannie W Y Chan
Journal:  Pharmaceutics       Date:  2022-02-20       Impact factor: 6.321

3.  3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T.

Authors:  Yulun Wu; Tobias C Wood; Fatemeh Arzanforoosh; Juan A Hernandez-Tamames; Gareth J Barker; Marion Smits; Esther A H Warnert
Journal:  MAGMA       Date:  2022-01-07       Impact factor: 2.310

Review 4.  Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors.

Authors:  Jinyuan Zhou; Moritz Zaiss; Linda Knutsson; Phillip Zhe Sun; Sung Soo Ahn; Silvio Aime; Peter Bachert; Jaishri O Blakeley; Kejia Cai; Michael A Chappell; Min Chen; Daniel F Gochberg; Steffen Goerke; Hye-Young Heo; Shanshan Jiang; Tao Jin; Seong-Gi Kim; John Laterra; Daniel Paech; Mark D Pagel; Ji Eun Park; Ravinder Reddy; Akihiko Sakata; Sabine Sartoretti-Schefer; A Dean Sherry; Seth A Smith; Greg J Stanisz; Pia C Sundgren; Osamu Togao; Moriel Vandsburger; Zhibo Wen; Yin Wu; Yi Zhang; Wenzhen Zhu; Zhongliang Zu; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2022-04-22       Impact factor: 3.737

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.